誉衡药业：关于董事、高级管理人员通过司法拍卖方式增持公司股份的自愿性披露公告

Core Points - Yu Heng International Investments Corporation and Oriental Keystone Investment Limited are auctioning a total of 99,678,123 shares of Yu Heng Pharmaceutical on a judicial auction platform from November 20 to November 21, 2025 [2] - The auction results show that the company's director and general manager, Guo Leifeng, along with his concerted action partner, Tibet Yupan Enterprise Management Partnership, successfully acquired 25 million shares, representing 1.12% of the company's total share capital [2]